PortfoliosLab logoPortfoliosLab logo
ACXP vs. QTUM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ACXP vs. QTUM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acurx Pharmaceuticals, Inc. (ACXP) and Defiance Quantum ETF (QTUM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACXP achieves a -29.72% return, which is significantly lower than QTUM's 52.13% return.


ACXP

1D
-2.78%
1M
-17.84%
YTD
-29.72%
6M
-46.65%
1Y
-74.86%
3Y*
-68.94%
5Y*
10Y*

QTUM

1D
-0.76%
1M
19.63%
YTD
52.13%
6M
48.25%
1Y
92.25%
3Y*
52.13%
5Y*
28.96%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ACXP vs. QTUM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ACXP
Acurx Pharmaceuticals, Inc.
-29.72%-84.71%-78.75%-3.77%-7.90%-45.23%
QTUM
Defiance Quantum ETF
52.13%36.65%50.54%39.86%-28.80%13.87%

Correlation

The correlation between ACXP and QTUM is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jun 28, 2021

0.17

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACXP vs. QTUM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACXP
ACXP Risk / Return Rank: 3131
Overall Rank
ACXP Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
ACXP Sortino Ratio Rank: 5050
Sortino Ratio Rank
ACXP Omega Ratio Rank: 4646
Omega Ratio Rank
ACXP Calmar Ratio Rank: 1010
Calmar Ratio Rank
ACXP Martin Ratio Rank: 2020
Martin Ratio Rank

QTUM
QTUM Risk / Return Rank: 9191
Overall Rank
QTUM Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
QTUM Sortino Ratio Rank: 9090
Sortino Ratio Rank
QTUM Omega Ratio Rank: 8787
Omega Ratio Rank
QTUM Calmar Ratio Rank: 9292
Calmar Ratio Rank
QTUM Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACXP vs. QTUM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ACXPQTUMDifference
Sharpe ratioReturn per unit of total volatility

-3.83

Sortino ratioReturn per unit of downside risk

-3.33

Omega ratioGain probability vs. loss probability

1.09

1.54

-0.45

Calmar ratioReturn relative to maximum drawdown

-0.82

6.08

-6.90

Martin ratioReturn relative to average drawdown

-1.02

22.92

-23.94

ACXP vs. QTUM - Sharpe Ratio Comparison

The current ACXP Sharpe Ratio is -0.30, which is lower than the QTUM Sharpe Ratio of 3.53. The chart below compares the historical Sharpe Ratios of ACXP and QTUM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ACXPQTUMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.30

3.53

-3.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.10

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.43

1.07

-1.50

Drawdowns

ACXP vs. QTUM - Drawdown Comparison

The maximum ACXP drawdown since its inception was -99.14%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for ACXP and QTUM.


Loading charts...

Drawdown Indicators


ACXPQTUMDifference

Max Drawdown

Largest peak-to-trough decline

-99.14%

-38.45%

-60.69%

Max Drawdown (1Y)

Largest decline over 1 year

-91.78%

-15.26%

-76.52%

Max Drawdown (3Y)

Largest decline over 3 years

-98.83%

-25.39%

-73.44%

Max Drawdown (5Y)

Largest decline over 5 years

-38.45%

Current Drawdown

Current decline from peak

-98.89%

-1.35%

-97.54%

Average Drawdown

Average peak-to-trough decline

-69.28%

-8.25%

-61.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

73.17%

4.04%

+69.13%

Volatility

ACXP vs. QTUM - Volatility Comparison

Acurx Pharmaceuticals, Inc. (ACXP) has a higher volatility of 16.47% compared to Defiance Quantum ETF (QTUM) at 9.78%. This indicates that ACXP's price experiences larger fluctuations and is considered to be riskier than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACXPQTUMDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.47%

9.78%

+6.69%

Volatility (6M)

Calculated over the trailing 6-month period

125.04%

20.32%

+104.72%

Volatility (1Y)

Calculated over the trailing 1-year period

253.64%

26.27%

+227.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

140.83%

26.56%

+114.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

140.83%

27.16%

+113.67%

Dividends

ACXP vs. QTUM - Dividend Comparison

ACXP has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.70%.


PositionTTM20252024202320222021202020192018
ACXP
Acurx Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QTUM
Defiance Quantum ETF
0.70%1.01%0.61%0.81%1.46%0.48%0.42%0.61%0.21%

Frequently Asked Questions


ACXP and QTUM have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ACXP has higher volatility (16.47%) compared to QTUM (9.78%). In terms of maximum drawdown, ACXP dropped -99.14% vs QTUM's -38.45%.

QTUM currently has the higher Sharpe Ratio (3.53 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACXP and QTUM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer